Prognostic Value and Immune Landscapes of Four Types of RNA Modification Writer-Related LncRNAs Signature in Lung Adenocarcinoma
Yongmei Qian, Qicheng Zhang, Yinghui Ren, Limin Cao, Sijia Zheng, Bingbing Li, Xiang Wu, Zhaowei Meng, Ke Xu · Journal of Cancer · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2024
Abstract
We developed an RNA modification writer-related seven-lncRNA signature prognostic model that was associated with prognosis, tumor microenvironment, and response to immunotherapy in LUAD patients. Among them, LINC01352, AC024075.1, AC005070.3, AL133445.2, AC005856.1, and LINC00968 were downregulated in LUAD, whereas AC092168.2 was upregulated. This model may be a valuable tool for personalized LUAD therapies.
Open the resolved locator · 10.7150/jca.96755
Metadata licence: OpenAlex metadata (CC0)